Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchsemaglutideglp-1c. eleganspreclinical

Semaglutide cuts chemotaxis and egg-laying in C. elegans, study reports

Worms exposed to 1 and 10 micromolar semaglutide showed reduced attraction to diacetyl plus delayed larval development.

PR
By Priya Raman · Science Reporter
Sep 22 20:00 ETSource: microPublication biology

The wire

  1. 01In microPublication Biology, wild-type N2 C. elegans exposed to semaglutide at 1 uM and 10 uM showed significantly reduced chemotaxis toward the odorant diacetyl, along with reduced egg-laying and delayed larval development.
  2. 02The authors argue the worm offers a tractable model for dissecting GLP-1 receptor agonist mechanisms at cellular resolution, relevant to appetite and reward circuitry questions.
  3. 03This is an invertebrate model with no annotated GLP-1 receptor orthologue discussed here, so the findings do not translate to human dosing or reproductive effects.

From the source

Semaglutide Reduces Odorant-Driven Chemotaxis and Reproductive Output in Caenorhabditis elegans

microPublication biology · 2026 · Kousnetzov S, Rodriguez ACI, Lopez RB et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →